Literature DB >> 32483197

Factors that influence the thymic selection of CD8αα intraepithelial lymphocytes.

Nadia S Kurd1,2, Ashley Hoover1,3, Jaewon Yoon1, Brian M Weist1,4, Lydia Lutes1, Shiao Wei Chan1, Ellen A Robey5.   

Abstract

Thymocytes bearing αβ T cell receptors (TCRαβ) with high affinity for self-peptide-MHC complexes undergo negative selection or are diverted to alternate T cell lineages, a process termed agonist selection. Among thymocytes bearing TCRs restricted to MHC class I, agonist selection can lead to the development of precursors that can home to the gut and give rise to CD8αα-expressing intraepithelial lymphocytes (CD8αα IELs). The factors that influence the choice between negative selection versus CD8αα IEL development remain largely unknown. Using a synchronized thymic tissue slice model that supports both negative selection and CD8αα IEL development, we show that the affinity threshold for CD8αα IEL development is higher than for negative selection. We also investigate the impact of peptide presenting cells and cytokines, and the migration patterns associated with these alternative cell fates. Our data highlight the roles of TCR affinity and the thymic microenvironments on T cell fate.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32483197     DOI: 10.1038/s41385-020-0295-5

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  43 in total

1.  Precursors of functional MHC class I- or class II-restricted CD8alphaalpha(+) T cells are positively selected in the thymus by agonist self-peptides.

Authors:  Andrew J Leishman; Laurent Gapin; Myriam Capone; Ed Palmer; H Robson MacDonald; Mitchell Kronenberg; Hilde Cheroutre
Journal:  Immunity       Date:  2002-03       Impact factor: 31.745

2.  Homeostasis of V alpha 14i NKT cells.

Authors:  Jennifer L Matsuda; Laurent Gapin; Stéphane Sidobre; William C Kieper; Joyce T Tan; Rhodri Ceredig; Charles D Surh; Mitchell Kronenberg
Journal:  Nat Immunol       Date:  2002-09-09       Impact factor: 25.606

3.  Thymus leukemia antigen controls intraepithelial lymphocyte function and inflammatory bowel disease.

Authors:  Danyvid Olivares-Villagómez; Yanice V Mendez-Fernandez; Vrajesh V Parekh; Saif Lalani; Tiffaney L Vincent; Hilde Cheroutre; Luc Van Kaer
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-12       Impact factor: 11.205

4.  The transcription factor T-bet is induced by IL-15 and thymic agonist selection and controls CD8αα(+) intraepithelial lymphocyte development.

Authors:  Christoph S N Klose; Katharina Blatz; Yannick d'Hargues; Pedro P Hernandez; Michael Kofoed-Nielsen; Juliane F Ripka; Karolina Ebert; Sebastian J Arnold; Andreas Diefenbach; Ed Palmer; Yakup Tanriver
Journal:  Immunity       Date:  2014-08-21       Impact factor: 31.745

5.  αβT cell receptors expressed by CD4(-)CD8αβ(-) intraepithelial T cells drive their fate into a unique lineage with unusual MHC reactivities.

Authors:  Hilde Cheroutre; Florence Lambolez; Sofia Mayans; Dariusz Stepniak; Sakina Palida; Alexandre Larange; Joanna Dreux; Britni Arlian; Ryo Shinnakasu; Mitchell Kronenberg
Journal:  Immunity       Date:  2014-08-14       Impact factor: 31.745

Review 6.  Selection of regulatory T cells in the thymus.

Authors:  Chyi-Song Hsieh; Hyang-Mi Lee; Chan-Wang J Lio
Journal:  Nat Rev Immunol       Date:  2012-02-10       Impact factor: 53.106

7.  Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire.

Authors:  Matthew A Burchill; Jianying Yang; Kieng B Vang; James J Moon; H Hamlet Chu; Chan-Wang J Lio; Amanda L Vegoe; Chyi-Song Hsieh; Marc K Jenkins; Michael A Farrar
Journal:  Immunity       Date:  2008-01       Impact factor: 31.745

8.  A two-step process for thymic regulatory T cell development.

Authors:  Chan-Wang Joaquim Lio; Chyi-Song Hsieh
Journal:  Immunity       Date:  2008-01       Impact factor: 31.745

9.  Clonal deletion and the fate of autoreactive thymocytes that survive negative selection.

Authors:  Leonid A Pobezinsky; Georgi S Angelov; Xuguang Tai; Susanna Jeurling; François Van Laethem; Lionel Feigenbaum; Jung-Hyun Park; Alfred Singer
Journal:  Nat Immunol       Date:  2012-04-29       Impact factor: 25.606

10.  A unique subset of self-specific intraintestinal T cells maintains gut integrity.

Authors:  Philippe Poussier; Terri Ning; Diponkar Banerjee; Michael Julius
Journal:  J Exp Med       Date:  2002-06-03       Impact factor: 14.307

View more
  5 in total

1.  Bcl-2 Is Necessary to Counteract Bim and Promote Survival of TCRαβ+CD8αα+ Intraepithelial Lymphocyte Precursors in the Thymus.

Authors:  Sharmila Shanmuganad; Sarah A Hummel; Vivian Varghese; David A Hildeman
Journal:  J Immunol       Date:  2022-01-07       Impact factor: 5.422

Review 2.  The perception and response of T cells to a changing environment are based on the law of initial value.

Authors:  Eric S Huseby; Emma Teixeiro
Journal:  Sci Signal       Date:  2022-05-31       Impact factor: 9.517

3.  How Thymocyte Deletion in the Cortex May Curtail Antigen-Specific T-Regulatory Cell Development in the Medulla.

Authors:  Chenglong Wang; Stephen R Daley
Journal:  Front Immunol       Date:  2022-05-25       Impact factor: 8.786

4.  Human Thymic CD10+ PD-1+ Intraepithelial Lymphocyte Precursors Acquire Interleukin-15 Responsiveness at the CD1a- CD95+ CD28- CCR7- Developmental Stage.

Authors:  Lore Billiet; Glenn Goetgeluk; Sarah Bonte; Stijn De Munter; Laurenz De Cock; Melissa Pille; Joline Ingels; Hanne Jansen; Karin Weening; Filip Van Nieuwerburgh; Tessa Kerre; Tom Taghon; Georges Leclercq; Bart Vandekerckhove
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

5.  Covalent TCR-peptide-MHC interactions induce T cell activation and redirect T cell fate in the thymus.

Authors:  Christopher Szeto; Pirooz Zareie; Rushika C Wirasinha; Justin B Zhang; Andrea T Nguyen; Alan Riboldi-Tunnicliffe; Nicole L La Gruta; Stephanie Gras; Stephen R Daley
Journal:  Nat Commun       Date:  2022-08-23       Impact factor: 17.694

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.